Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Halal pharmaceuticals are those medicines that stringently adhere to Shariah law. More specifically, halal pharmaceuticals refer to medicines that should not contain any parts of animals (dogs, pigs and ones particularly with pointed teeth), insects (bees), alcohol and other substances prohibited as 'haram' under the Shariah law.
Scope of the Report:
In the last several years, global market of Halal Pharmaceuticals developed rapidly, with an average growth rate of 22.98%. In the next few years, Halal Pharmaceuticals industry will maintain increasing at a high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
Southeast Asia and NAME is the main production places, with a revenue market share nearly 62% and 18% in 2016. Southeast Asia and NAME also is the main consumption region with market share 58% and 26% in 2016. The revenue is about 205.79 M USD the consumption need is around 36.7 B USD in 2016 and there is a huge gap in there.
The classification of Halal Pharmaceuticals includes Tablets, Syrups, Capsules and Other. The proportion of Tablets in 2016 is about 46%, and the proportion is in increasing trend from 2012 to 2016.
The worldwide market for Halal Pharmaceuticals is expected to grow at a CAGR of roughly 14.5% over the next five years, will reach 540 million US$ in 2024, from 240 million US$ in 2019, according to a new WMR study.
This report focuses on the Halal Pharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
Health Care Products
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Halal Pharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Halal Pharmaceuticals, with price, sales, revenue and global market share of Halal Pharmaceuticals in 2017 and 2018.
Chapter 3, the Halal Pharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Halal Pharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Halal Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Halal Pharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.